NCT00000318
Completed
Phase 2
Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot
InterventionsBuprenorphine
DrugsBuprenorphine
Overview
- Phase
- Phase 2
- Intervention
- Buprenorphine
- Conditions
- Opioid-Related Disorders
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Enrollment
- 202
- Locations
- 1
- Primary Endpoint
- Opioid and cocaine use
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Arms & Interventions
1
Maintenance treatment with daily medication
Intervention: Buprenorphine
2
Maintenance treatment with thrice-weekly medication
Intervention: Buprenorphine
Outcomes
Primary Outcomes
Opioid and cocaine use
Time Frame: 26 weeks
Social and psychological functioning
Time Frame: 26 weeks
AIDS risk behavior
Time Frame: 26 weeks
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Alternate-Day Buprenorphine Administration. Phase IV - 5Opioid-Related DisordersNCT00000223National Institute on Drug Abuse (NIDA)
Completed
Phase 2
Buprenorphine Maintenance for Opioid Addicts - 3Opioid-Related DisordersNCT00000204Yale University
Completed
Phase 2
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2Opioid-Related DisordersSubstance-Related DisordersNCT00000319Yale University
Completed
Phase 2
Alternate Day Buprenorphine Administration, Phase IX - 14Opioid-Related DisordersNCT00000232University of Vermont
Completed
Phase 2
Alternate-Day Buprenorphine Administration. Phase VII - 8Opioid-Related DisordersNCT00000226National Institute on Drug Abuse (NIDA)